Healthtech Series A Investors & VC Firms
2309 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
Novalis Biotech
GhentPre-Seed–Series A
7 people
TechnoFounders
Pre-Seed–Growth
10 people
Fourward Ventures
Los AngelesSeed–Series A
3 people
Polytech Ecosystem Ventures
Pre-Seed–Series A
3 people
Shenzhen Capital Group
ShenzhenSeed–Growth$1M – $3.5M
3 people
Targeted Technology Funds
San AntonioSeed–Series A
6 people
The Colorado Impact Fund
DenverSeed–Growth$500K – $2M
6 people
TRICAPITAL
Scottish BordersSeed–Series A$315K – $2.5M
6 people
ECONA AG
BerlinSeed–Growth
1 person
InHealth Ventures
LondonPre-Seed–Series A$500K – $3M
5 people
Level One Fund
MiamiSeed–Series A
5 people
NYBC Ventures
New YorkSeed–Series B
8 people
SyndicateRoom
CambridgePre-Seed–Series A
5 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
2 people
Banyan Ventures
New YorkPre-Seed–Series B
2 people
Lanta Digital Ventures
BarcelonaPre-Seed–Series A
9 people
Highlight Capital
NanjinSeed–Series B
1 person
Criteria Bio Ventures
BarcelonaSeed–Series B
7 people
Delphinus Venture Capital
AarhusPre-Seed–Series B$108K – $1.1M
7 people
Lavni Ventures
NewarkSeed–Series B$225K – $1.7M
7 people
Moving Capital
Los AngelesSeed–Series B
7 people
NGEN Partners
New YorkSeed–Growth$5M – $20M
4 people
QC·VENTURES
ViennaSeed–Late Stage$216K – $4.3M
7 people
Scottish Co-Investment Fund
Seed–Growth$130K – $2.6M
10 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Healthtech Investors & VC Firms (4190)Series A Investors & VC Firms in United States (3838)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Healthtech Investors & VC Firms in United States (2436)Series A Investors & VC Firms in Europe (2383)
Data sourced from public filings and firms' own websites — see our methodology.













































































